Abstract

BackgroundAnnual influenza vaccination is an important public health measure to prevent influenza infections and is strongly recommended for cardiovascular disease (CVD) patients, especially in the current coronavirus disease 2019 (COVID-19) pandemic. The aim of this study is to develop a machine learning model to identify Korean adult CVD patients with low adherence to influenza vaccinationMethodsAdults with CVD (n = 815) from a nationally representative dataset of the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V) were analyzed. Among these adults, 500 (61.4%) had answered "yes" to whether they had received seasonal influenza vaccinations in the past 12 months. The classification process was performed using the logistic regression (LR), random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGB) machine learning techniques. Because the Ministry of Health and Welfare in Korea offers free influenza immunization for the elderly, separate models were developed for the < 65 and ≥ 65 age groups.ResultsThe accuracy of machine learning models using 16 variables as predictors of low influenza vaccination adherence was compared; for the ≥ 65 age group, XGB (84.7%) and RF (84.7%) have the best accuracies, followed by LR (82.7%) and SVM (77.6%). For the < 65 age group, SVM has the best accuracy (68.4%), followed by RF (64.9%), LR (63.2%), and XGB (61.4%).ConclusionsThe machine leaning models show comparable performance in classifying adult CVD patients with low adherence to influenza vaccination.

Highlights

  • Annual influenza vaccination is an important public health measure to prevent influenza infections and is strongly recommended for cardiovascular disease (CVD) patients, especially in the current coronavirus disease 2019 (COVID-19) pandemic

  • Data collection and preparation Data were obtained from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES) conducted by the Korea Center for Disease Control and Prevention (KCDC) from January 2010 to December 2012

  • Among CVD patients aged ≥ 65 years, there are two significant variables associated with influenza vaccination, namely, the sex and national insurance state

Read more

Summary

Introduction

Annual influenza vaccination is an important public health measure to prevent influenza infections and is strongly recommended for cardiovascular disease (CVD) patients, especially in the current coronavirus disease 2019 (COVID-19) pandemic. Influenza is an infectious disease of the respiratory system and the outbreak of influenza occurs worldwide in a seasonal manner, usually during the winter season in temperate climates. It is highly contagious and affects people via droplet contact. Several meta-analyses and systematic reviews have revealed a strong association between influenza infection and acute myocardial infarction [3, 5]. These reviews strongly recommend influenza vaccination for CVD patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call